RxSight, Inc. To Participate in the Truist Securities Medtech Conference
06 June 2024 - 6:05AM
RxSight, Inc., an ophthalmic medical device company dedicated to
providing high-quality customized vision to patients following
cataract surgery, today announced plans to participate in the
upcoming Truist Securities MedTech Conference.
RxSight’s management is scheduled to participate in a fireside
chat on Tuesday, June 18, 2024, at 12:05 p.m. Pacific Time / 3:05
p.m. Eastern Time. Interested parties may access a live and
archived webcast of the presentation at:
https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated
to providing high-quality customized vision to patients following
cataract surgery. The RxSight® Light Adjustable Lens system,
comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+™,
collectively the “LAL”), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that can be adjusted after
surgery, enabling doctors to customize and deliver high-quality
vision to patients after cataract surgery. Additional information
about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:Oliver MoravcevicVP,
Investor Relationsomoravcevic@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Aug 2024 to Sep 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Sep 2023 to Sep 2024